|
Fibrocystic Breast
Disease
References
Abrams, A. Use of vitamin E in chronic cystic mastitis. N.
Engl. J. Med. 1965; 272: 2388.
Allen, S.S., Froberg, D.C. The effect of decreased caffeine
consumption on benign proliferative breast disease: a
randomized clinical trial. Surgery 1985; 91: 263.
Allen, S.S., Froberg, D.G. The effect of decreased caffeine
consumption on benign proliferative breast disease: a
randomized clinical trial. Surgery 1987 Jun; 101(6):
720-30.
American Cancer Society. Benign Breast Conditions 1991,
1997. Atlanta, GA: American Cancer Society.
AMA. American Medical Association's Council on Scientific
Affairs. Caffeine labeling, a report on the safety of dietary
caffeine. JAMA 1984; 252: 803-6.
AMA. The American Medical Association Encyclopedia of
Medicine 1989. New York: Random House.
Anderson, J.W., Bridges, S.R. Dietary fiber content of
selected foods. Am. J. Clin. Nutr. 1988; 47: 440-7.
Anon. Benign breast conditions. Reinsurance Notes 1998; 1:
12.
Anon. Professional Guide to Signs & Symptoms, Third
Edition 2000. Springhouse, PA: Springhouse.
Arnao, M.B., Sanchez-Bravo, J., Acosta, M.
Indole-3-carbinol as a scavenger of free radicals. Biochem.
Mol. Biol. Int. 1996 Aug; 39(6): 1125-34.
Augustin, L.S., Dal Maso, L., La Vecchia, C., Parpinel, M.,
Negri, E., Vaccarella, S., Kendall, C.W., Jenkins, D.J.,
Francesch, S. Dietary glycemic index and glycemic load, and
breast cancer risk: a case-control study. Ann. Oncol. 2001
Nov; 12(11): 1533-8.
Ayres, J., Gidwani, G. The "luteal breast:" hormonal and
sonographic investigations of benign breast disease in
patients with cyclic mastalgia. Fertil. Steril. 1983; 40:
779.
Band, P.R., Deschamps, M., Falardeau, M., Ladouceur, J.,
Cote, J. Treatment of benign breast disease with vitamin A.
Prev. Med. 1984; 13(5): 549-54.
Banni, S., Angioni, E., Casu, V., Melis, M.P., Carta, G.,
Corongiu, F.P., Thompson, H., Ip, C. Decrease in linoleic acid
metabolites as a potential mechanism in cancer risk reduction
by conjugated linoleic acid. Carcinogenesis 1999 Jun; 20(6):
1019-24.
Barrett-Connor, E., Goodman-Gruen, D. The epidemiology of
DHEAs and cardiovascular disease. Ann. N.Y. Acad. Sci. 1995;
774: 259-70.
Bassett, L.W., Kimme-Smith, C. Breast sonography. Am. J.
Roentgenol. 1991; 156: 449-55.
Bates, G.W., Whitworth, N.S. Effects of obesity on sex
steroid metabolism. J. Chron. Dis. 1982; 35(12): 893-6.
BCERF. Fruits and Vegetables and the Risk of Breast Cancer
1998 Dec. Program on Breast Cancer and Environmental Risk
Factors in New York State. Ithaca, NY: Cornell University.
Belch, J.J., Hill, A. Evening primrose oil and borage oil
in rheumatologic conditions. Am. J. Clin. Nutr. 2000 Jan;
71(1, Suppl.): 352S-356S.
BeLieu, R.M. Mastodynia. Obstet. Gynecol. Clin. North Am.
1994 Sep; 21(3): 461-77.
Blum, I., Marilus, R., Barasch, E., Sztern, M., Bruhis, S.,
Kaufman, H. Severe sexual impairment produced by morbid
obesity. Report of a case. Int. J. Obes. 1988; 12(3):
185-9.
Bodian, C.A. Benign breast diseases, carcinoma in situ, and
breast cancer risk. Epidemiol. Rev. 1993a; 15: 177-87.
Bodian, C.A., Perzin, K.H., Lattes, R., Hoffmann, P.,
Abernathy, T.G. Prognostic significance of benign
proliferative breast disease. Cancer 1993b Jun 15; 71(12):
3896-3907.
Bodian, C.A., Perzin, K.H., Lattes, R., Hoffmann, P.
Reproducibility and validity of pathologic classifications of
benign breast disease and implications for clinical
applications. Cancer 1993c Jun 15; 71(12): 3908-13.
Boyd, N.F., McGuire, V., Shannon, P., Cousins, M., Kriukov,
V., Mahoney, L., Fish, E., Lickley, L., Lockwood, G.,
Tritchler, D. Effect of a low-fat high-carbohydrate diet on
symptoms of cyclical mastopathy. Lancet 1988; 16; 2(8603):
128-32.
Boyd, N.F., Greenberg, C., Lockwood, G. et al. Effects at
two years of a low-fat, high-carbohydrate diet on radiologic
features of the breast: results from a randomized trial.
Canadian Diet and Breast Cancer Prevention Study Group. J.
Natl. Cancer. Inst. 1997 Apr 2; 89(7): 488-96.
Boyle, C.A., Berkowitz, G.S., LiVolsi, V.A., Ort, S.,
Merino, M.J., White, C., Kelsey, J.L. Caffeine consumption and
fibrocystic breast disease: a case-control epidemiologic
study. J. Natl. Cancer Inst. 1984; 72(5): 1015-9.
Bradlow, H.L., Michnovicz, J.J., Halper, M., Miller, D.G.,
Wong, G.Y., Osborne, M.P. Long-term responses of women to
indole-3-carbinol or a high fiber diet. Cancer Epidemiol.
Biomarkers Prev. 1994 Oct-Nov; 3(7): 591-5.
Bradlow, H.L., Sepkovic, D.W., Telang, N.T., Osborne, M.P.
Multifunctional aspects of the action of indole-3-carbinol as
an antitumor agent. Ann. N.Y. Acad. Sci. 1999a; 889:
204-13.
Bradlow, H.L., Telang, N.T., Sepkovic, D.W., Osborne, M.P.
Phytochemicals as modulators of cancer risk. Adv. Exp. Med.
Biol. 1999b; 472: 207-21.
Bundred, N.J., West, R.R., O'Dowd, J., Mansel, R.E. Is
there an increased risk of breast cancer in women who have had
a breast cyst aspirated? Br. J. Cancer 1991; 64: 953-5.
Chatterji, U. Identifying the Breast Cancer Target for
Indole-3-Carbinol (unpublished). Postdoctorate Fellowship
2001-2002. Berkeley, CA: University of California.
Cheung, K.L. Management of cyclical mastalgia in oriental
women: pioneer experience of using gamolenic acid (Efamast) in
Asia. Aust. N.Z. J. Surg. 1999 Jul; 69(7): 492-4.
Cho, S.Y., Park, J.Y., Park, E.M., Choi, M.S., Lee, M.K.,
Jeon, S.M., Jang, M.K., Kim, M.J., Park, Y.B. Alternation of
hepatic antioxidant enzyme activities and lipid profile in
streptozotocin-induced diabetic rats by supplementation of
dandelion water extract. Clin. Chim. Acta 2002 Mar; 317(1-2):
109-17.
Clarke, R.P., Schlenker, E.D., Merrow, S.B. Nutrient
intake, adiposity, plasma total cholesterol, and blood
pressure of rural participants in the (Vermont) Nutrition
Program for Older Americans (Title III). Am. J. Clin. Nutr.
1981 Sep; 34(9): 1743-51.
Corsini, E., Lucchi, L., Meroni, M., Racchi, M., Solerte,
B., Fioravanti, M., Viviani, B., Marinovich, M., Govoni, S.,
Galli, C.L. In vivo dehydroepiandrosterone restores
age-associated defects in the protein kinase C signal
transduction pathway and related functional responses. J.
Immunol. 2002 Feb 15; 168(4): 1753-8.
Cover, C.M., Hsieh, S.J., Cram, E.J., Hong, C., Riby, J.E.,
Bjeldanes, L.F., Firestone, G.L. Indole-3-carbinol and
tamoxifen cooperate to arrest the cell cycle of MCF-7 human
breast cancer cells. Cancer Res. 1999 Mar 15; 59(6):
1244-51.
Despres, J.P., Pascot, A., Lemieux, I. Risk factors
associated with obesity: a metabolic perspective. Ann.
Endocrinol. 2000 Dec; 61(Suppl. 6): 31-8 (in French).
Ditmar, F.W., Luh, W. Treatment of fibrocystic mastopathy
with hydrolytic enzymes. Int. J. Exp. Clin. Chemother. 1993;
6(1): 9-20.
Ernster V.L. The epidemiology of benign breast disease.
Epidemiol. Rev. 1981; 3: 184-202.
Estes, N. Mastodynia due to fibrocystic disease of the
breast controlled with thyroid hormone. Am. J. Surg. 1981;
Dec; 142(6): 764?6.
Fentiman, I.S., Caleffi, M., Brame, K. et al. Double-blind
controlled trial of tamoxifen therapy for mastalgia. Lancet
1986; 1: 287.
Fine, R.E., Israel, P.Z., Walker, L.C., Corgan, K.R.,
Greenwald, L.V., Berenson, J.E., Boyd, B.A., Oliver, M.K.,
McClure, T., Elberfeld, J. A prospective study of the removal
rate of imaged breast lesions by an 11-gauge vacuum-assisted
biopsy probe system. Am. J. Surg. 2001 Oct; 182(4):
335-40.
Fontana, J.A., Nervi, C., Shao, Z.M., Jetten, A.M. Retinoid
antagonism of estrogen-responsive transforming growth factor
alpha and pS2 gene expression in breast carcinoma cells.
Cancer Res. 1992 Jul 15; 52(14): 3938-45.
Franceschi, S., Favero, A., Decarli, A., Negri, E., La
Vecchia, C., Ferraroni, M., Russo, A., Salvini, S., Amadori,
D., Conti, E. et al. Intake of macronutrients and risk of
breast cancer. Lancet 1996 May 18; 347(9012): 1351-6;
comments, Lancet 1996 May 18; 347(9012): 1346 and Lancet 1996
Jul 13; 348(9020): 137-8; discussion, Lancet 1996 Jul 13;
348(9020): 138.
Gateley, C.A., Maddox, P.R., Pritchard, G.A., Sheridan, W.,
Harrison, B.J., Pye, J.K., Webster, D.J., Hughes, L.E.,
Mansel, R.E. Plasma fatty acid profiles in benign breast
disorders. Br. J. Surg. 1992 May; 79(5): 407-9.
Gateley, C.A., Mansel, R.E. Management of cyclical breast
pain. Br. J. Hosp. Med. 1990 May; 43(5): 330-2.
Gateley, C.A., Mansel, R.E. Management of the painful and
nodular breast. Br. Med. Bull. 1991 Apr; 47(2): 284-94.
Ghent, W.R., Eskin, B.A., Low, D.A., Hill, L.P. Iodine
replacement in fibrocystic disease of the breast. Can. J.
Surg. 1993; 36(5): 453-60.
Goldin, B.R., Adlercreutz, H., Dwyer, J.T., Swenson, L.,
Warram, J.H., Gorbach, S.L. Effect of diet on excretion of
estrogens in pre- and postmenopausal women. Cancer Res. 1981
Sep; 41(9, Pt. 2): 3771-3.
Goldin, B.R., Adlercreutz, H., Gorbach, S.L., Warram, J.H.,
Dwyer, J.T., Swenson, L., Woods, M.N. Estrogen excretion
patterns and plasma levels in vegetarian and omnivorous women.
N. Engl. J. Med. 1982 Dec 16; 307(25): 1542-7.
Greenblatt, R.B., Vasquez, J., Samaras, C. Fibrocytic
breast disease: current status of diagnosis and treatment.
Postgrad. Med. 1982 Mar; 71(3): 159-63, 166-8.
Hagymasi, K., Kocsis, I., Lugasi, A., Feher, J., Blazovics,
A. Extrahepatic biliary obstruction: can silymarin protect
liver function? Phytother. Res. 2002 Mar; 16(Suppl. 1):
S78-S80.
Henderson, M., Pike, M.C., Bernstein, L., Ross, R.K. Breast
cancer. In Cancer Epidemiology and Prevention, Second Edition
1996. Schottenfeld, D., Fraumeni, J.F., Eds. New York: Oxford
University Press.
Horner, N.K., Lampe, J.W. Potential mechanisms of diet
therapy for fibrocystic breast conditions show inadequate
evidence of effectiveness. J. Am. Diet. Assoc. 2000 Nov;
100(11): 1368-80.
Huang, Z., Willett, W.C., Colditz, G.A., Hunter, D.J.,
Manson, J.E., Rosner, B., Speizer, F.E., Hankinson, S.E. Waist
circumference, waist:hip ratio, and risk of breast cancer in
the Nurses' Health Study. Am. J. Epidemiol. 1999 Dec 15;
150(12): 1316-24.
Hudgins, L.C., Hellerstein, M.K., Seidman, C.E., Neese,
R.A., Tremaroli, J.D., Hirsch, J. Relationship between
carbohydrate-induced hypertriglyceridemia and fatty acid
synthesis in lean and obese subjects. J. Lipid Res. 2000 Apr;
41(4): 595-604.
Hunt, S.C., Williams, R.R., Adams, T.D. Biochemical and
anthropometric characterization of morbid obesity in a large
Utah pedigree. Obes. Res. 1995 Sep; 3(Suppl. 2):
165S-172S.
Hurley, S.F., Hart, S., Susil, B. Prevalence, Screening and
Management of Atypical Hyperplasia and Lobular Carcinoma In
Situ 1997. Canberra: National Health and Medical Research
Council/National Breast Cancer Centre.
Imaginis. Breast health (non-cancerous breast issues).
Imaginis Newsletter 2000 Nov 13. Durham, NC: Imaginis
Corporation.
Imaginis. Soy and breast cancer. Imaginis Newsletter 2001
Jan 20. Durham, NC: Imaginis Corporation.
Inukai, T., Matsutomo, R., Tayama, K., Aso, Y., Takemura,
Y. Relation between the serum level of C-peptide and risk
factors for coronary heart disease and diabetic
microangiopathy in patients with type-2 diabetes mellitus.
Exp. Clin. Endocrinol. Diabetes 1999; 107(1): 40-5.
Ip, M.M., Masso-Welch, P.A., Shoemaker, S.F., Shea-Eaton,
W.K., Ip, C. Conjugated linoleic acid inhibits proliferation
and induces apoptosis of normal rat mammary epithelial cells
in primary culture. Exp. Cell Res. 1999a Jul 10; 250(1):
22-34.
Ip, C., Banni, S., Angioni, E., Carta, G., McGinley, J.,
Thompson, H.J., Barbano, D., Bauman, D. Conjugated linoleic
acid-enriched butter fat alters mammary gland morphogenesis
and reduces cancer risk in rats. J. Nutr. 1999b Dec; 129(12):
2135-42.
Jackman, R.J., Lamm, R.L. Stereotactic histologic biopsy in
breasts with implants. Radiology 2002 Jan; 222(1): 157-64.
Kaizer, L., Boyd, N.F., Kriukov, V., Tritchler, D. Fish
consumption and breast cancer risk: an ecological study. Nutr.
Cancer 1989; 12(1): 61-8.
Kaplan, N.M. The deadly quartet. Upper-body obesity,
glucose intolerance, hypertriglyceridemia, and hypertension.
Arch. Intern. Med. 1989 Jul; 149(7): 1514-20.
Kimura, M., Tanaka, S., Yamada, Y., Kiuchi, Y., Yamakawa,
T., Sekihara, H. Dehydroepiandrosterone decreases serum tumor
necrosis factor-alpha and restores insulin sensitivity:
independent effect from secondary weight reduction in
genetically obese Zucker fatty rats. Endocrinology 1998 Jul;
139(7): 3249-53.
Kosina, P., Kren, V., Gebhardt, R., Grambal, F., Ulrichova,
J., Walterova, D. Antioxidant properties of silybin
glycosides. Phytother. Res. 2002 Mar; 16(Suppl. 1):
S33-S39.
Kumar, S., Mansel, R.E., Hughes, L.E. et al. Prolactin
response to thyrotropin-releasing hormone stimulation and
dopaminergic inhibition in benign breast disease. Cancer 1984
Mar 15; 53(6): 1311-5.
Kumar, S., Mansel, R.E., Hughes, L.E., Edwards, C.A.,
Scanlon, M.F. Prediction of response to endocrine therapy in
pronounced cyclical mastalgia using dynamic tests of prolactin
release. Clin. Endocrinol. 1985 Dec; 23(6): 699-704.
Kurzman, I.D., Panciera, D.L., Miller, J.B., MacEwen, E.G.
The effect of dehydroepiandrosterone combined with a low-fat
diet in spontaneously obese dogs: a clinical trial. Obes. Res.
1998 Jan; 6(1): 20-8. Lark, S.M. The Woman's Health Companion
1996. Berkeley, CA: Celestial Arts.
La Vecchia, C., Franceschi, S., Parazzini, F., Regallo, M.,
Decarli, A., Gallus, G., Di Pietro, S., Tognoni, G. Benign
breast disease and consumption of beverages containing
methylxanthines. J. Natl. Cancer Inst. 1985; 74(5):
995-1000.
Leijd, B. Cholesterol and bile acid metabolism in obesity.
Clin. Sci. 1980 Sep; 59(3): 203-6.
Leonardi, M. Hormonal contraception and benign breast
disease: evaluation of a treatment protocol for fibrocystic
disease with mastalgia. Min. Ginecol. 1997; 49(6): 271-6.
Leowattana, W. DHEA(S): the fountain of youth. J. Med.
Assoc. Thai 2001 Oct; 84(Suppl. 2): S605-S612.
London, R.S., Sundaram, G.S., Murphy, L. et al. The effect
of vitamin E on mammary dysplasia: a double-blind study.
Obstet. Gynecol. 1985; 65: 104.
London, R.S., Sundaram, G.S., Schultz, M., Nair, P.P.,
Goldstein, P.J. Endocrine parameters and alpha-tocopherol
therapy of patients with mammary dysplasia. Cancer Res. 1981;
41(9, Pt. 2): 3811-3.
Lopez, S.P., Martinez, E.J., Reillo, M. Treatment of breast
fibrocystic disease with tanazol. Acta Ginecol. 1996; 53(10):
304-9.
Lopez-Rosales, C., Romero Espinosa, R.E., Vazquez, J.
Treatment of fibrocystic breast disease with lisuride.
Ginecol. Obstet. Mex. 1991; 59: 358-61.
Lundstrom, E., Wilczek, B., von Palffy, A., Soderqvist, G.,
von Schoultz, B. Mammographic breast density during hormone
replacement therapy: effects of continuous combination,
unapposed transdermal, and low-potency estrogen regimens.
Climacteric 2001 Mar; 4(1): 42?8.
Maganini, R.O., Klem, D.A., Huston, B.J., Bruner, E.S.,
Jacobs, H.K. Upgrade rate of core biopsy-determined atypical
ductal hyperplasia by open excisional biopsy. Am. J. Surg.
2001 Oct; 182(4): 355-8.
Maillard, V., Bougnoux, P., Ferrari, P., Jourdan, M.L.,
Pinault, M., Lavillonniere, F., Body, G., Le Floch, O.,
Chajes, V. N-3 and N-6 fatty acids in breast adipose tissue
and relative risk of breast cancer in a case-control study in
Tours, France. Int. J. Cancer 2002 Mar 1; 98(1): 78-83.
Maliakal, P.P., Wanwimolruk, S. Effect of herbal teas on
hepatic drug metabolizing enzymes in rats. J. Pharm.
Pharmacol. 2001 Oct; 53(10): 1323-9.
Mancuso, P., Whelan, J., DeMichele, S.J., Snider, C.C.,
Guszcza, J.A., Claycombe, K.J., Smith, G.T., Gregory, T.J.,
Karlstad, M.D. Effects of eicosapentaenoic and gamma-linolenic
acid on lung permeability and alveolar macrophage eicosanoid
synthesis in endotoxic rats. Crit. Care Med. 1997 Mar; 25(3):
523-32.
Mansel, R.E., Gateley, C.A., Harrison, B.J. et al. Effects
and tolerability of n-6 essential fatty acid supplementation
in patients with recurrent breast cysts. J. Nutr. Med. 1990a;
1: 195-200.
Mansel, R.E., Harrison, B.J., Melhuish, J., Sheridan, W.,
Pye, J.K., Pritchard, G., Maddox, P.R., Webster, D.J., Hughes,
L.E. A randomized trial of dietary intervention with essential
fatty acids in patients with categorized cysts. Ann. N.Y.
Acad. Sci. 1990b; 586: 288-94.
Mansel, R.E., Pye, J.K., Hughes, L.E. Effects of essential
fatty acids on cyclical mastalgia and noncyclical breast
disorders. In Omega-6 Essential Fatty Acids 1990c, pp. 557-67.
Horrobon, D., Ed. New York: Wiley-Liss.
Mansel, R.E., Wisbey, J.R., Hughes, L.E. Controlled trial
of the antigonadotropin danazol in painful nodular benign
breast disease. Lancet 1982 Apr 24; 1(8278): 928-30.
Martinez, L., Castilla, J.A., Gil, T., Molina, J., Alarcon,
J.L., Marcos, C., Herruzo, A. Thyroid hormones in fibrocystic
breast disease. Eur. J. Endocrinol. 1995 Jun; 132(6):
673-6.
Mayo Clinic. Menopause: women's sex hormones: a refresher
course. Mayo Clinic Women's HealthSource 2001. Rochester, MN:
Mayo Foundation for Medical Education and Research.
Mazy, S., Hustin, J. Van Reepinghen, P. Phyllodes tumor of
the breast. J. Belge Radiol. (JBR-BTR) 1999 Jun; 82(3):
118.
McBean, L.D. Emerging health benefits of CLA (conjugated
linoleic acid). Dairy Council Digest 1999. Rosement, IL:
National Dairy Council.
McFayden, I.J., Forrest, A.P., Chetty, U., Raab, G.
Cyclical breast pain?some observations and the difficulties in
treatment. Br. J. Clin. Pract. 1992 Autumn; 46(3): 161-4.
Meeks, M.L., Mahaffey, K.W., Katz, M.D. Danazol increases
with anticoagulant effect of warfarin. Ann. Pharmacother.
1992; 26(5): 641-2.
Meng, Q., Yuan, F., Goldberg, I.D., Rosen, E.M., Auborn,
K., Fan, S. Indole-3-carbinol is a negative regulator of
estrogen receptor-alpha signaling in human tumor cells. J.
Nutr. 2000 Dec; 130(12): 2927-31.
Meyer, E.C., Sommers, D.K., Reitz, C.J., Mentis, H. Vitamin
E and benign breast disease. Surgery 1990; 107(5): 549-51.
Michnovicz, J.J., Adlercreutz, H., Bradlow, H.L. Changes in
levels of urinary estrogen metabolites after oral
indole-3-carbinol treatment in humans. J. Natl. Cancer Inst.
1997 May 21; 89(10): 718-23.
Minton, J.P., Abou-Issa, H. Nonendocrine theories of the
etiology of benign breast disease. World J. Surg. 1989
Nov-Dec; 13(6): 680-4.
Minton, J.P., Abou-Issa, H., Reiches, N., Roseman, J.M.
Clinical and biochemical studies on methylxanthine-related
fibrocystic breast disease. Surgery 1981; 90(2): 299-304.
Minton, J.P., Foecking, M.K., Webster, D.J., Matthews, R.H.
Caffeine, cyclic nucleotides, and breast disease. Surgery
1979; 86(1): 105-9.
Mishell, D.R. Noncontraceptive benefits of oral
contraceptives. J. Reprod. Med. 1993; 38: 1021-9.
Mishra, S.K., Sharma, A.K., Salila, M., Srivastava, A.,
Bal, S., Ramesh, V. Efficacy of low fat diet in the treatment
of benign breast disease. Natl. Med. J. India 1994 Mar-Apr;
7(2): 60-2.
Molteni, A., Brizio-Molteni, L., Persky, V. In vitro
hormonal effects of soybean isoflavones. J. Nutr. 1995 Mar;
125(3, Suppl.): 751S-756S.
Mowatt, T. Gourmet treats to keep you healthy. Life
Extension Magazine 1998 Jun; 4(6): 22-6. Ft. Lauderdale, FL:
Life Extension Foundation.
Murialdo, G., Nobili, F., Rollero, A., Gianelli, M.V.,
Copello, F., Rodriguez, G., Polleri, A. Hippocampal perfusion
and pituitary-adrenal axis in Alzheimer's disease.
Neuropsychobiology 2000; 42(2): 51-7.
National Cancer Institute. Benign Breast Lumps and Other
Benign Breast Changes 2001a. Bethesda, MD
(http://rex.nci.nih.gov).
National Cancer Institute. Understanding Breast Changes.
About Breast Lumps and Other Changes 2001b. Bethesda, MD
(http://cancernet.nci.nih.gov).
NBCC. Benign Breast Disease: Summary of Risk Factors for
Breast Cancer 1999 Jul 15. Campersdown, NSW, Australia:
National Breast Cancer Centre.
Nestler, J.E., Arlasini, C.O., Clore, J.N. et al.
Dehydroepiandrosterone reduces serum low density lipoprotein
levels and body fat but not insulin sensitivity in men. J.
Clin. Endocrinol. Metabol. 1988; 66(1): 57-61.
NIEHS. Background Information. Indole-3-Carbinol (I3C),
700-06-1 June 2000. Research Triangle Park, NC: National
Institute of Environmental Health Sciences
(http://ntp-server.nih.gov/htdocs/Chem_Background/ExecSumm/Indolecarbinol.html).
Nimrod, A.C., Benson, W.H. Environmental estrogenic effects
of alkylphenol thoxylates. Crit. Rev. Toxicol. 1996; 26:
335-64.
Norlock, F.E. Benign breast pain in women: a practical
approach to evaluation and treatment. J. Am. Med. Womens
Assoc. 2002 Spring; 57(2): 85-90.
Ohsumi, S., Takashima, S., Aogi, K., Ishizaki, M., Mandai,
K. Breast biopsy for mammographically detected non-palpable
lesions using a vacuum-assisted biopsy device (Mammotome) and
an upright-type stereotactic mammography unit. Jpn. J. Clin.
Oncol. 2001 Nov; 31(11): 527-31.
Oza, A.M., Boyd, N.F. Mammographic parenchymal patterns: a
marker of breast cancer risk. Epidemiol. Rev. 1993; 15:
196-208.
Ozdemir, A., Konus, O., Nas, T., Erbas, G., Cosar, S.,
Isik, S. Mamographic and ultrasonic study of changes in the
breast related to HRT. Int. J. Gynecol. Obstet. 1999; 67(1):
23-32.
Pain, J.A., Cahill, C.J. Management of cyclical mastalgia.
Br. J. Clin. Pract. 1990; 44: 454-6.
Pastides, H., Najjar, M.A., Kelsey, J.L. Estrogen
replacement therapy and fibrocystic breast disease. Am. J.
Prev. Med. 1987; 3(5): 282-6.
Peress, M.R., Kreutner, A.K., Mathur, R.S., Williamson,
H.O. Female pseudohermaphroditism with somatic chromosomal
anomaly in association with in utero exposure to danazol. Am.
J. Obstet. Gynecol. 1982; 142(61): 708-9.
Perlet, C., Schneider, P., Amaya, B., Grosse, A., Sittek,
H., Reiser, M.F., Heywang-Kobrunner, S.H. MR-guided vacuum
biopsy of 206 contrast-enhancing breast lesions. Rofo
Fortschr. Geb. Rontgenstr. Neuen Bildgeb. Verfahr. 2002 Jan;
174(1): 88-95.
Polleri, A., Gianelli, M.V., Murialdo, G. Dementia: a
neuroendocrine perspective. J. Endocrinol. Invest. 2002 Jan;
25(1): 73-83.
Pye, J.K., Mansel, R.E., Hughes, L.E. Clinical experience
of drug treatments for mastalgia. Lancet 1985 Aug 17; 2(8451):
373-7.
Quagliani, D. Complex carbohydrates: they're the best thing
since sliced bread. Better Homes & Gardens 1997 May.
Rohan, T.E., Miller, A.B. A cohort study of oral
contraceptive use and risk of benign breast disease. Int. J.
Cancer 1999; 82(2): 191-6.
Roloff, J. Why grass makes for better milk. Science News
1997 Oct 11.
Rose, D.P., Boyar, A.P., Cohen, C., Strong, L.E. Effect of
a low-fat diet on hormone levels in women with cystic breast
disease. I. Serum steroids and gonadotropins. J. Natl. Cancer
Inst. 1987; 78(4): 623-6.
Rose, D.P., Cohen, L.A., Berke, B., Boyar, A.P. Effect of a
low-fat diet on hormone levels in women with cystic breast
disease. II. Serum radioimmunoassayable prolactin and growth
hormone and bioactive lactogenic hormones. J. Natl. Cancer
Inst. 1987 Apr; 78(4): 627-31.
Rosenberg, L., Miller, D.R., Helmrich, S.P., Kaufman, D.W.,
Schottenfeld, D., Stolley, P.D., Shapiro, S. Breast cancer and
the consumption of coffee. Am. J. Epidemiol. 1985; 122(3):
391-9.
Russell, L.C. Caffeine restriction as initial treatment for
breast pain. Nurse Practitioner 1989; 14(2): 36-7, 40.
Saller, R., Meier, R., Brignoli, R. The use of silymarin in
the treatment of liver diseases. Drugs 2001; 61(14):
2035-63.
Santamaria, L., Dell'Orti, M., Bianchi Santamaria, A.
Beta-carotene supplementation associated with intermittent
retinal administration in the treatment of premenopausal
mastodynia. Boll. Chim. Farm. 1989; 128(9): 284-7.
Schairer, C., Brinton, L.A., Hoover, R.N. Methylxanthines
and benign breast disease. Am. J. Epidemiol. 1986; 124(4):
603-11.
Scott, P.M. Oral contraceptives in the 90s. Physician
Assist. 1993; 17(12): 19-28.
Siiteri, P.K. Adipose tissue as a source of hormones. Am.
J. Clin. Nutr. 1987 Jan; 45(1, Suppl.): 277-82.
Simpson, E.R. Aromatization of androgens in women: current
concepts and findings. Fertil. Steril. 2002 Apr; 77(Suppl. 4):
6-10.
Singh, R.B., Niaz, M.A., Agarwal, P., Beegum, R., Rastogi,
S.S., Singh, N.K. Epidemiologic study of central obesity,
insulin resistance and associated disturbances in the urban
population of North India. Acta Cardiol. 1995; 50(3):
215-25.
Sitruk-Ware, R., Sterkers, N., Mauvais-Jarvis, P. Benign
breast disease. I. Hormonal investigation. Obstet. Gynecol.
1979; 53: 457.
Takayanagi, R., Goto, K., Suzuki, S., Tanaka, S., Shimoda,
S., Nawata, H. Dehydroepiandrosterone (DHEA) as a possible
source for estrogen formation in bone cells: correlation
between bone mineral density and serum DHEA-sulfate
concentration in postmenopausal women, and the presence of
aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human
osteoblasts. Mech. Ageing Dev. 2002 Apr; 123(8): 1107-14.
Terry, P., Wolk, A., Persson, I., Magnusson, C. Brassica
vegetables and breast cancer risk. JAMA 2001 Jun 20; 285(23):
2975-7.
Vanhala, M.J., Pitkajarvi, T.K., Kumpusalo, E.A., Takala,
J.K. Obesity type and clustering of insulin
resistance-associated cardiovascular risk factors in
middle-aged men and women. Int. J. Obes. Relat. Metab. Disord.
1998 Apr; 22(4): 369-74.
Van Horn, L. Fiber, lipids, and coronary heart disease. A
statement for healthcare professionals from the Nutrition
Committee, American Heart Association. Circulation 1997 Jun
17; 95(12): 2701-4.
Widschwendter, M., Berger, J., Muller, H.M., Zeimet, A.G.,
Marth, C. Epigenetic downregulation of the retinoic acid
receptor-beta2 gene in breast cancer. J. Mammary Gland Biol.
Neoplasia 2001 Apr; 6(2): 193-201.
Wong, G.Y., Bradlow, L., Sepkovic, D., Mehl, S., Mailman,
J., Osborne, M.P. Dose-ranging study of indole-3-carbinol for
breast cancer prevention. J. Cell. Biochem. Suppl. 1997;
28-29: 111-6.
Wu, Q., Dawson, M.I., Zheng, Y., Hobbs, P.D., Agadir, A.,
Jong, L., Li, Y., Liu, R., Lin, B., Zhang, X.K. Inhibition of
trans-retinoic acid-resistant human breast cancer cell growth
by retinoid X receptor-selective retinoids. Mol. Cell. Biol .
1997 Nov; 17(11): 6598-6608.
Writing Group for the Women's Health Initiative
Investigators. Risks and benefits of estrogen plus progestin
in healthy postmenopausal women: principal results from the
Women's Health Initiative randomized controlled trial. JAMA
2002 Jul 17; 288(3): 321-33.
Yang, L.M., Tin, U.C., Wu, K., Brown, P. Role of retinoid
receptors in the prevention and treatment of breast cancer. J.
Mammary Gland Biol. Neoplasia 1999 Oct; 4(4): 377-88.
Yang, S., Fu, Z., Wang, F., Cao, Y., Han, R.
Anti-mutagenicity activity of dehydroepiandrosterone. Zhonghua
Zhong Liu Za Zhi 2002 Mar; 24(2): 137-140 (in Chinese).
Yen, S.S., Morales, A.J., Khorram, O. Replacement of DHEA
in aging men and women. Ann. N.Y. Acad. Sci. 1995 Dec 29; 774:
128-42.
Zumoff, B. Hormonal abnormalities in obesity. Acta Med.
Scand. Suppl. 1988; 723: 153-60.
Zych, F., Mizia-Stec, K., Mucha, Z., Zych-Twardowska, E.
Fibrocystic disease of breast and pituitary-thyroid axis
function. Pol. Merkuriusz Lek. 1996 Oct; 1(4): 227-8 (in
Polish).
|